INTELLIGENCE IN ACTION

HIMSS19 Showed Glimpses of a Bright Future, But Also Problem Solving in the Here and Now

March 25, 2019

Dr. Andrew Mellin, Surescripts VP of Medical Informatics Physician has been to nearly 20 HIMSS conferences over his career, wearing different hats as a physician, as a vendor and as a health system leader. But this one, his first one as a member of the Surescripts team, felt different, as he explained in a recent article on LinkedIn.

“With my many conversations with provider leaders, technology companies, healthcare associations, and entrepreneurs—I felt like I was at the center of something big and impactful, [as Surescripts] is a facilitator that brings together virtually every major stakeholder in healthcare, including arch competitors, with a common goal to improve safety, lower costs and ensure quality care,” says Dr. Mellin.

“To me, the most profound impact the Surescripts Network Alliance will have in the next few years is removing the opaque reality of an individual person’s financial responsibility for a prescription,” he says.

Dr. Mellin had the opportunity to facilitate a panel at the HIMSS Interoperability Showcase, with a focus on the need for, and transformative power of, prescription price transparency at the point of care. The panelists, all participants in the Network Alliance, talked frankly about the very real need for this technology and that it can be a real game changer in the care journey. Not just for the patient, but for the prescriber, as well, which can help alleviate the very real phenomenon of physician burnout, noted a number of the panelists.

“This HIMSS was different for me—it was not about cool technologies and future promises, but it was about solving difficult, industry-wide problems today. The rapid adoption and value realization for prescription price transparency tools is the manifestation of years of work by my colleagues and people across the industry to build a foundation of trust, technology, and standards,” Dr. Mellin says. “And, I’m excited to work across the industry to put this tool in every provider’s hands and to work with the Surescripts Network Alliance to solve the next hard challenge.”

To read Dr. Mellin’s full take on HIMSS19, check out his article on LinkedIn. And for more on Surescripts’ experience at HIMSS19, be sure to view our highlights video

Related Articles

March 04, 2020

Prescription Price Transparency: Good for Patients, Good for Health Plans

Receiving a diagnosis at a routine doctor’s appointment can be incredibly scary, even for something as treatable as type 2 diabetes. But the right price transparency tools—or lack thereof—can make (or break) that experience for a patient.  Read more...
February 25, 2020

Price Transparency: It’s in the Best Interest of Patients and Providers

“In all my years in health IT this is one of the most exciting and most rapidly adopted clinical decision support tools I’ve ever been associated with,” said Andrew Mellin, MD and vice president of Medical Informatics at Surescripts, referring to Surescripts’ prescription price transparency tool Read more...
February 18, 2020

Patients Are Ready to Talk Dollars with Their Doctors

With more skin in the game than ever before, patients are becoming savvy, engaged and discerning consumers. They know that the name-brand drug with the $300 monthly price tag may not be the only option. They want a healthcare provider who has the information needed to compare and guide them to alternatives that achieve the same or similar outcome. Read more...

INTELLIGENCE IN ACTION, DELIVERED TO YOUR INBOX